Gut‐Kidney Axis: Novel Insights in Kidney Diseases
Chemistry & Biodiversity · 2025
DOI: 10.1002/cbdv.202501506 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Chemistry & Biodiversity, 2025. Verfasst von Yasunori Iwata und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology and Rheumatology, Kanazawa University, Kanazawa, Japan. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Renal Insufficiency, Chronic, Kidney, Kidney Diseases. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 51 Literaturangaben.
Abstract (Originalsprache)
Chronic kidney disease (CKD) is increasingly prevalent worldwide, and its management is an urgent issue. Understanding of its pathophysiology and the development of new treatment methods are critical. In recent years, gut microbiota reportedly contributes to the homeostasis of systemic organs and the pathogenesis of diseases. Also, in kidney disease, alterations in the gut microbiota (dysbiosis) have been observed and are deeply involved in pathophysiology. d ‐Amino acids derived from gut microbiota change in concentration in the body concomitant with dysbiosis. d ‐Serine and d ‐alanine have been shown to have renal tubular protective effects in acute tubular necrosis, suggesting their potential as renal therapeutic agents. We have been evaluating the therapeutic effects of d ‐alanine, metabolic enzyme inhibitors, and food products containing d ‐amino acids in human CKD. The recent association between gut and systemic organ dysfunction not only reveals new mechanisms of disease but also indicates the possibility of new therapeutic strategies. This article provides an overview of new insights into kidney disease, gut microbiota, and its metabolites.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Nephrology and Rheumatology, Kanazawa University, Kanazawa, Japan.
- Division of Laboratory Medicine, Kanazawa University Hospital, Kanazawa, Japan.
- Division of Nutrition Management, Kanazawa University Hospital, Kanazawa, Japan.
- Division of Infection Control, Kanazawa University Hospital, Kanazawa, Japan.
- KAGAMI Inc., Osaka, Japan.
- Division of Nephrology, Department of General Medicine, School of Medicine, Faculty of Medical Sciences, University of Fukui, Fukui, Japan.
ORCID-Profile: Yasunori Iwata
Zitieren
APA
Iwata, Y., Nakade, Y., Tokumaru, T., Oshima, M., Mita, M., Toyama, T., Linh, H. T., & Wada, T. (2025). Gut‐Kidney Axis: Novel Insights in Kidney Diseases. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202501506
Vancouver
Iwata Y, Nakade Y, Tokumaru T, Oshima M, Mita M, Toyama T, et al. Gut‐Kidney Axis: Novel Insights in Kidney Diseases. Chemistry & Biodiversity. 2025. doi:10.1002/cbdv.202501506
BibTeX
@article{Iwata2025,
author = {Iwata, Yasunori and Nakade, Yusuke and Tokumaru, Toshiaki and Oshima, Megumi and Mita, Masashi and Toyama, Tadashi and Linh, Hoan Thuy and Wada, Takashi},
title = {Gut‐Kidney Axis: Novel Insights in Kidney Diseases},
journal = {Chemistry & Biodiversity},
year = {2025},
doi = {10.1002/cbdv.202501506}
}
EUVIMED